Quantity limit

A quantity limit caps how much of a drug your plan will pay for in a given period — typically expressed as units per 28 or 30 days. It is one of several utilization-management tools, alongside prior authorization and step therapy, that decide not only whether a drug is covered but how much of it you can get at a time.

For GLP-1 pens, the limit is usually one pen or one carton per 28 days, matching the labeled once-weekly dosing. That sounds unremarkable until a real-world detail collides with it. Wegovy and Zepbound are dispensed as month-length supplies keyed to a specific dose strength, and titration steps happen on the label’s own four-week schedule. If your clinician moves you up early because of an incomplete response, or you need a partial refill after a device failure, the quantity limit is what blocks it.

Four-week supplies and calendar months also drift apart. Thirteen 28-day cycles fit into a year; twelve calendar months do not line up with them. Over a year that mismatch can leave a gap, which is why some patients find themselves a few days short every autumn.

The rules behind these limits come from your pharmacy benefit manager rather than your prescriber, and they can be appealed. A quantity-limit exception generally needs a clinical justification in writing: the labeled dosing that supports the request, the response so far, and why the standard quantity is inadequate.

Worth asking: what the exact quantity limit is on your plan, whether an exception process exists and what it requires, and what to do if a pen is damaged or wasted mid-cycle. Our prior-authorization letter generator, appeal strategy guide and pen leftover calculator help you document the request and account for what is actually in the device.